Clinical Trial: A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895460) titled 'A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)' on Feb. 27.

Brief Summary: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial on the Treatment of Bronchial Asthma with Budesonide Formoterol Combined with Immune Modulators (Staphylococcus and Neisseria Tablets)

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condition: Bronchial Asthma

Intervention: DRUG: Budesonide Formoterol

Investigator Selection

DRUG: Placebo

Placebo: 0.3 mg/tablet, 4 tablets per dose, 3 times per day, for a course of 3 months

D...